EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Adjunctive fecal microbiota transplantation for major depressive disorder: A randomized, double-blind, placebo-controlled trial

Jing Li, Yaping Wang, Ruinan Li, Huanwei Huang, Xuequan Zhu, Xiaozheng Li, Zuoli Sun, Ling Zhang, Peng Zheng, Yi He, Jing Liu, Xueshan Zhang und 8 weitere

Cell Host & Microbe · 2026-07 · 34 (7) · 1367-1382.e7

DOI: 10.1016/j.chom.2026.05.017 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Cell Host & Microbe, 2026-07. Verfasst von Jing Li und 19 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory of Mental Disorders, National Clinical Research Center for Mental Disorders, National Center for Mental Disorders, Beijing And…. Hauptthemen laut MEDLINE: Fecal Microbiota Transplantation, Major Depressive Disorder. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Beijing Municipal Science and Technology Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gut microbiota may influence antidepressant treatment outcomes, yet whether targeted modulation can enhance efficacy remains unclear. We conducted a randomized, double-blind, placebo-controlled trial in patients with major depressive disorder, administering a 2-week course of fecal microbiota transplantation (FMT) capsules or placebo as an adjunct to escitalopram (ChiCTR2300071421). Remission rates at week 8 did not differ significantly between groups, but FMT produced greater reductions in Hamilton Depression Rating Scale, 17-item version (HAMD-17) scores at weeks 2 and 8. FMT was well-tolerated with a safety profile comparable to placebo. Multi-omics analyses show durable donor microbial engraftment and enrichment of beneficial Lachnospiraceae and Oscillospiraceae taxa. Microbial remodeling is accompanied by an increase in serum bile acids that correlate with the alleviation of depressive symptoms. Mediation analysis supports a bile-acid-mediated suppression of inflammatory pathways linking microbial changes to antidepressant effects. Overall, FMT may provide a safe avenue to enhance escitalopram efficacy through microbiota-directed regulation of bile-acid metabolism and inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fecal Microbiota TransplantationMajor Depressive DisorderHumansDouble-Blind MethodFemaleBile Acids and SaltsTreatment OutcomeMaleAdultEscitalopramMiddle AgedGastrointestinal MicrobiomeFecesAntidepressive Agents

Stichwörter der Autor:innen

bile acidsfecal microbiota transplantationgut microbiotainflammationmajor depressive disorderrandomized controlled trial

Substanzen

Bile Acids and SaltsEscitalopramAntidepressive Agents

Autor:innen und Institutionen

  • Beijing Key Laboratory of Mental Disorders, National Clinical Research Center for Mental Disorders, National Center for Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing 100088, China.
  • College of Life Science and Oceanography, Shenzhen University, Shenzhen 518060, China.
  • Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China; NHC Key Laboratory of Diagnosis and Treatment on Brain Functional Diseases, The First Affiliated Hospital…
  • Beijing Key Laboratory of Mental Disorders, National Clinical Research Center for Mental Disorders, National Center for Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing 100088, China. Elect…
  • Beijing Key Laboratory of Mental Disorders, National Clinical Research Center for Mental Disorders, National Center for Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing 100088, China; Advan…

Förderung

  • National Natural Science Foundation of China
  • Beijing Municipal Science and Technology Commission

Zitieren

APA

Li, J., Wang, Y., Li, R., Huang, H., Zhu, X., Li, X., Sun, Z., Zhang, L., Zheng, P., He, Y., Liu, J., Zhang, X., Ren, S., Liu, M., Wang, H., Luo, Y., Wang, F., Zhou, J., Yang, J., & Wang, G. (2026). Adjunctive fecal microbiota transplantation for major depressive disorder: A randomized, double-blind, placebo-controlled trial. Cell Host & Microbe, 34(7), 1367-1382.e7. https://doi.org/10.1016/j.chom.2026.05.017

Vancouver

Li J, Wang Y, Li R, Huang H, Zhu X, Li X, et al. Adjunctive fecal microbiota transplantation for major depressive disorder: A randomized, double-blind, placebo-controlled trial. Cell Host & Microbe. 2026;34(7):1367-1382.e7. doi:10.1016/j.chom.2026.05.017

BibTeX
@article{Li2026,
  author = {Li, Jing and Wang, Yaping and Li, Ruinan and Huang, Huanwei and Zhu, Xuequan and Li, Xiaozheng and Sun, Zuoli and Zhang, Ling and Zheng, Peng and He, Yi and Liu, Jing and Zhang, Xueshan and Ren, Siyu and Liu, Mingxia and Wang, Haixia and Luo, Yanting and Wang, Fei and Zhou, Jingjing and Yang, Jian and Wang, Gang},
  title = {Adjunctive fecal microbiota transplantation for major depressive disorder: A randomized, double-blind, placebo-controlled trial},
  journal = {Cell Host & Microbe},
  year = {2026},
  volume = {34},
  number = {7},
  pages = {1367--1382.e7},
  doi = {10.1016/j.chom.2026.05.017}
}
Kostenlos starten →